Verition Fund Management
BLUE

Verition Fund Management’s bluebird bio BLUE Stock Holding History

Verition Fund Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,056
Closed -$42.1K – 3253
2024
Q3 		$42.1K Buy
+4,056
New +$67.4K ﹤0.01% 3049
2023
Q4 		– Sell
-2,683
Closed -$163K – 2352
2023
Q3 		$163K Buy
+2,683
New +$188K ﹤0.01% 2026
2023
Q1 		– Sell
-1,350
Closed -$187K – 2165
2022
Q4 		$187K Sell
1,350
-487
-27% -$68.6K ﹤0.01% 1772
2022
Q3 		$233K Buy
+1,837
New +$208K ﹤0.01% 2399
2021
Q3 		– Sell
-1,186
Closed -$491K – 1919
2021
Q2 		$491K Sell
1,186
-187
-14% -$74.1K ﹤0.01% 1103
2021
Q1 		$536K Buy
+1,373
New +$676K 0.01% 833
2020
Q4 		– Sell
-309
Closed -$216K – 1113
2020
Q3 		$216K Sell
309
-160
-34% -$125K ﹤0.01% 911
2020
Q2 		$371K Buy
+469
New +$354K 0.01% 719
2020
Q1 		– Sell
-349
Closed -$396K – 640
2019
Q4 		$396K Buy
+349
New +$379K 0.01% 753
2019
Q2 		– Sell
-579
Closed -$1.18M – 1073
2019
Q1 		$1.18M Buy
+579
New +$1.02M 0.05% 347
2018
Q2 		– Sell
-526
Closed -$1.16M – 1085
2018
Q1 		$1.16M Buy
+526
New +$1.34M 0.09% 315
2015
Q3 		– Sell
-178
Closed -$389K – 526
2015
Q2 		$389K Buy
+178
New +$363K 0.07% 253

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Verition Fund Management's BLUE Position: Q4 2024 in Review

Verition Fund Management sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 4,056 shares — an estimated $42.1K sold.

Verition Fund Management first reported a position in BLUE in Q2 2015 and held it in 12 quarters. The position peaked at $1.18M in Q1 2019. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • Verition Fund Management reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • Verition Fund Management sold 4,056 bluebird bio shares in Q4 2024, an estimated $42.1K.
  • Verition Fund Management first reported a position in bluebird bio in Q2 2015 and held it in 12 quarters.
  • Verition Fund Management's bluebird bio position peaked at $1.18M in Q1 2019.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on Verition Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.